![Results from the TRAP trial presented at ESTRO24](https://oncodaily.com/pub/uploads/2024/06/Pi7_Tool_GPsoi_bXEAAjHXp-e1718026861405.jpg)
Photo from ESTRO/X
Jun 10, 2024, 12:19
Results from the TRAP trial presented at ESTRO24
ESTRO shared on X/Twitter:
“Results from the TRAP trial presented at ESTRO24: this phase-II trial explores the addition of SBRT to androgen receptor pathway inhibitor treatment in patients with oligoprogressive castrate-resistant prostate cancer.”
Source: ESTRO/X
Jun 17, 2024, 20:53